Japanese Airlines Stock News

Daiichi Sankyo Company, Limited's ( TSE:4568 ) investors are due to receive a payment of ¥39.00 per share on 24th of...

Key Insights Institutions' substantial holdings in Sekisui Chemical implies that they have significant influence over...

Key Insights Japan Data Science ConsortiumLtd's significant retail investors ownership suggests that the key decisions...

KIOXIA America announced that Kioxia, Tsubakimoto Chain and EAGLYS have formed a collaboration to develop AI-driven image recognition technology that automates identification of products in logistics workflows, with the jointly built system already showcased at the December 2025 International Robot Exhibition in Tokyo. The project is interesting because it links Tsubakimoto Chain’s conveyor and logistics expertise with Kioxia’s Memory-Centric AI and EAGLYS’s image analytics to address...

Earlier this week, TOPPAN Holdings Inc. held a board meeting to consider a new executive structure, while subsidiary TOPPAN Inc. and Tekscend Photomask Corp. prepared to showcase advanced semiconductor photomasks, packaging technologies, and FC-BGA substrates targeting AI and data center demand at SEMICON Japan 2025. Together with an Electronics Business Strategy Briefing for analysts and investors, these moves highlight TOPPAN’s push to reposition its electronics business around...

If you are wondering whether Mitsubishi UFJ Financial Group still offers good value after such a strong run, or if you are arriving too late, this breakdown is designed to help you decide with a cool head. The stock has slipped 2.7% over the last week but is still up 5.4% over the past month, 31.7% year to date, 36.5% over 1 year, and an eye catching 254.1% over 3 years and 557.6% over 5 years. This naturally raises the question of how much upside is left from here. Recent market attention...

Nintendo (TSE:7974) is back in the spotlight as worries over rising memory costs for its upcoming Switch 2 console collide with unexpected holiday price cuts, wiping roughly ¥2 trillion from its market value. See our latest analysis for Nintendo. That nervous reaction is hitting a stock that still looks strong in the rear-view mirror, with a year-to-date share price return of about 26 percent and a three-year total shareholder return above 110 percent. This suggests long term momentum remains...

Nexon’s CEO Junghun Lee recently argued that “every game company” now uses AI, while stressing that human creativity still separates standout titles from average ones, as debate intensified over the ethical limits of AI in its hit game Arc Raiders. Following criticism, Embark Studios clarified that Arc Raiders relies on machine learning and reinforcement learning rather than generative AI, putting Nexon’s broader technology choices and stance on AI ethics under a spotlight. We’ll now examine...

As Asian markets navigate a complex landscape marked by mixed economic indicators and evolving investor sentiment, the region's technology sector continues to capture attention with its potential for high growth. In this environment, identifying promising tech stocks involves looking for companies that demonstrate resilience and innovation amidst shifting global trends and local challenges.

Key Insights The considerable ownership by state or government in Tokyo Metro indicates that they collectively have a...

In December 2025, Sumitomo Pharma America presented updated Phase 1/2 clinical data at the 67th American Society of Hematology Annual Meeting in Orlando, highlighting its investigational oral menin inhibitor enzomenib for relapsed or refractory acute leukemia and PIM1 kinase inhibitor nuvisertib for relapsed or refractory myelofibrosis. The promising response rates and favorable safety profiles reported for these two early-stage oncology candidates point to a strengthening hematology...

As Asian markets navigate a complex economic landscape marked by fluctuating manufacturing activity and evolving monetary policies, investors are increasingly on the lookout for opportunities that may be undervalued amid these conditions. Identifying stocks that are trading below their intrinsic value can be a strategic move, offering potential for growth as market dynamics continue to shift.

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...

Fuyo General Lease Co., Ltd.'s ( TSE:8424 ) investors are due to receive a payment of ¥79.00 per share on 25th of June...

The board of MISUMI Group Inc. ( TSE:9962 ) has announced that it will be paying its dividend of ¥25.62 on the 25th of...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

The Solasto Corporation ( TSE:6197 ) share price has done very well over the last month, posting an excellent gain of...

Earlier this month, Sony Group outlined plans to incorporate AI more deeply into its future games, aligning with a broader industry shift toward AI-enhanced development and in-game experiences. The announcement underscored that while AI can streamline production and personalize gameplay, Sony and peers still view human creativity as the ultimate differentiator in game quality. We’ll now consider how Sony’s push to embed AI in future games could influence its investment narrative centered on...

If you are wondering whether SoftBank Group’s huge tech bets and sprawling portfolio make the current share price a bargain or a bubble, you are not alone. That is exactly what we are going to unpack here. The stock has risen 102.1% year to date and 104.4% over the last year, even after a sharp 16.2% pullback in the past month and an 11.9% rebound over the last week. As a result, the risk reward profile is shifting fast. Much of that volatility has been driven by headlines around SoftBank’s...

On December 9, 2025, AGC Inc. held a board meeting to approve changes to its Board of Directors, Audit & Supervisory Board, and Executive Officers, while AGC Biologics earlier partnered with ATUM to integrate the Leap-In Transposase expression platform into its global Cell Line Development Center of Excellence. This collaboration adds a modern transposase-based system alongside AGC Biologics’ CHEF1 Expression Technology, aiming to shorten drug developers’ timelines and broaden the company’s...

If you are wondering whether Mitsubishi Electric is still good value after such a strong run, you are not alone. This article is going to unpack what the current price might really be telling us. The stock has climbed 6.9% over the last week, 7.6% over the past month, and an eye catching 72.7% year to date, building on gains of 78.3% over 1 year and 257.4% over 3 years. Investors have been reacting to Mitsubishi Electric's ongoing strategic push into factory automation and energy efficient...

As global markets navigate the anticipation of interest rate decisions and mixed economic signals, investors are eyeing potential opportunities in dividend stocks to enhance portfolio stability amid these dynamic conditions. In this environment, a good dividend stock is characterized by consistent payouts and financial resilience, offering a reliable income stream even as market uncertainties persist.

In recent days, Tokyo-listed Metaplanet outlined plans to launch novel perpetual preferred share structures, including its MARS instrument, to raise capital dedicated to expanding its Bitcoin holdings, with a related Mercury digital credit instrument targeted for Japan’s perpetual preferred market by early 2026. By securing a 12‑month head start in Japan after Strategy ruled out issuing similar preferred equity locally, Metaplanet is positioning these new instruments as a potentially...

Kura Oncology and Kyowa Kirin recently reported new Phase 1a/1b data showing that KOMZIFTI (ziftomenib), combined with venetoclax and azacitidine, produced encouraging antileukemic activity and a favorable safety profile in patients with acute myeloid leukemia harboring NPM1 mutations or KMT2A rearrangements, with results presented at the 67th ASH Annual Meeting. An important insight is that these findings support ongoing registrational trials that aim to position KOMZIFTI as a core menin...